GS
GlobeStar Therapeutics Corporation
GSTC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $124.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive EV/EBITDA 72.89x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
100 /100
Excellent ROIC 174.56%
Asset turnover N/A
ROE N/A
Debt
0 /100
High Net debt/EBITDA 54.43x
Current ratio 0.00x
Int. coverage -20.28x
Stability
27 /100
Unstable Profitable years 0
Beta 1.11x
EPS volatility 620.41%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre GSTC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James C. Katzaroff
Employees
0
Headquarters
New York